HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EU meeting

This article was originally published in The Rose Sheet

Executive Summary

European Partnership to Promote Alternative Approaches to Animal Testing (EPAA) will present its draft action plan during European Commission Health & Consumer Protection DG Inter-Committee Coordination Group meeting April 5, according to 1agenda posted to EC's Web site. EPAA was founded in November by industry and government reps to explore ways to reduce animal use; group intends to undertake projects such as evaluating new in vitro tests, current test method quality and intelligent chemical testing strategies (2"The Rose Sheet" Nov. 14, 2005, p. 8). Coordination group, comprising Scientific Committee on Consumer Products, Scientific Committee on Emerging and Newly-Identified Health Risks and Scientific Committee on Health and Environmental Risks, also will discuss new requests to each committee and their positions on alternative testing methods...
Advertisement

Related Content

European Partnership Aims To Facilitate Animal Alternatives
European Partnership Aims To Facilitate Animal Alternatives
Advertisement
UsernamePublicRestriction

Register

RS013827

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel